摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 1198074-44-0

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
1198074-44-0
化学式
C18H24F3NO2
mdl
——
分子量
343.389
InChiKey
DJVCMOMBDFOIPD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.03
  • 重原子数:
    24.0
  • 可旋转键数:
    6.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    39.19
  • 氢给体数:
    0.0
  • 氢受体数:
    3.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    、 sodium hydroxide 作用下, 以 四氢呋喃乙醇 为溶剂, 生成 4-(3-cyclohexyl-5-(trifluoromethyl)pyridin-2-yl)butanoic acid
    参考文献:
    名称:
    Synthesis of novel tetrahydroisoquinoline bronchodilators
    摘要:
    The synthesis and bronchorelaxing effects of a series of novel tetrahydroisoquinoline amides are described. The compounds were evaluated for their ability to relax LTD4 contracted isolated human small airways ex-vivo. Several compounds demonstrated highly efficacious bronchorelaxing properties. Cinnamide 71 was selected for further studies and constitutes a promising candidate as a novel bronchorelaxing agent for the treatment of pulmonary disorders. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.07.057
  • 作为产物:
    描述:
    ethyl 4-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)butanoatebromozinc(1+),cyclohexane 在 [1,3-bis(2,6-diisopropyl-phenyl)imidazol-2-ylidene](3-chloropyridyl)-palladium(II) dichloride 作用下, 以 四氢呋喃 为溶剂, 反应 40.0h, 以27%的产率得到
    参考文献:
    名称:
    Synthesis of novel tetrahydroisoquinoline bronchodilators
    摘要:
    The synthesis and bronchorelaxing effects of a series of novel tetrahydroisoquinoline amides are described. The compounds were evaluated for their ability to relax LTD4 contracted isolated human small airways ex-vivo. Several compounds demonstrated highly efficacious bronchorelaxing properties. Cinnamide 71 was selected for further studies and constitutes a promising candidate as a novel bronchorelaxing agent for the treatment of pulmonary disorders. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.07.057
点击查看最新优质反应信息